Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rita C G Novaes

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Bioethica|November 6, 2009
Maria Rita C G Novaes, Dirce Guilhem, Fernando Lolas
Experimental Biology and Medicine (Maywood, N.J.)|November 11, 2008
Immunological, hematological, and glycemia effects of dietary supplementation with Agaricus sylvaticus on patients' colorectal cancerRenata C Fortes, Maria Rita C G Novaes, Viviane L Recôva, et al.
Frontiers in Pharmacology|June 9, 2020
The High "Cost" of Experimental Drugs Obtained Through Health Litigation in BrazilRicardo Eccard da Silva, Elisangela da Costa Lima, Maria Rita C G Novaes, et al.
Frontiers in Pharmacology|February 7, 2018
Factors Contributing to Exacerbating Vulnerabilities in Global Clinical TrialsRicardo E da Silva, Angélica A Amato, Dirce B Guilhem, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Bioethica|November 6, 2009
Maria Rita C G Novaes, Dirce Guilhem, Fernando Lolas
Experimental Biology and Medicine (Maywood, N.J.)|November 11, 2008
Immunological, hematological, and glycemia effects of dietary supplementation with Agaricus sylvaticus on patients' colorectal cancerRenata C Fortes, Maria Rita C G Novaes, Viviane L Recôva, et al.
Frontiers in Pharmacology|June 9, 2020
The High "Cost" of Experimental Drugs Obtained Through Health Litigation in BrazilRicardo Eccard da Silva, Elisangela da Costa Lima, Maria Rita C G Novaes, et al.
Frontiers in Pharmacology|February 7, 2018
Factors Contributing to Exacerbating Vulnerabilities in Global Clinical TrialsRicardo E da Silva, Angélica A Amato, Dirce B Guilhem, et al.
Pageof 1